(RTTNews) - Beckman Coulter Diagnostics, the clinical diagnostics unit of science and technology firm Danaher Corp. (DHR), announced Monday that the new DxC 500i Clinical Analyzer received 510(k ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

The global cell based assays market was projected to attain US$ 20.2 billion in 2023. It is anticipated to garner a 6.4% CAGR ...

The rising incidence of blood disorders and chronic illnesses, along with an increase in accidents and emergency care requirements, is fueling the demand for blood and blood products. Additionally, ...

Russell Bradley Named President & General Manager of CNSideDr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide Board of ...

The Business Research Company The Business Research Company's Vitamin Biomarkers Global Market Report 2025 – Market Size, Trends, And Forec ...

Danaher Corporation (NYSE ... in this release reflect only continuing operations unless otherwise noted. Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced ...

BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry ...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an ...

Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...

Innovative superRCA technology from Rarity Bioscience AB enhances flow cytometry, expanding oncology research possibilities ...